We are live on ! Find out more
BFIC

Bedell Frazier Investment Counselling Portfolio holdings

AUM $495M
1-Year Est. Return 29.32%
This Fund
S&P 500
This Quarter Est. Return
+10.13%
1 Year Est. Return
+29.32%
3 Year Est. Return
+72.55%
5 Year Est. Return
+91.45%
10 Year Est. Return
+350.44%
AUM
$198M
AUM Growth
+$19.1M
Cap. Flow
+$3.79M
Cap. Flow %
1.92%
Top 10 Hldgs %
49.48%
Holding
55
New
4
Increased
21
Reduced
19
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 24.63%
2 Energy 15.25%
3 Communication Services 14.85%
4 Consumer Discretionary 11.47%
5 Healthcare 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAX
26
abrdn Asia-Pacific Income Fund
FAX
$601M
$3.46M 1.75%
91,728
-1,642
-2% -$61.3K
CLF icon
27
Cleveland-Cliffs
CLF
$6.99B
$3.26M 1.65%
216,350
+89,300
+70% +$1.51M
BBD icon
28
Banco Bradesco
BBD
$34.9B
$2.91M 1.48%
+511,932
New +$2.99M
LNKD
29
DELISTED
LinkedIn Corporation
LNKD
$2.56M 1.3%
14,930
+230
+2% +$37.2K
BCRH
30
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
$2.49M 1.26%
126,600
+7,000
+6% +$127K
VXX
31
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$2.47M 1.25%
5,402
+263
+5% +$153K
VZ icon
32
Verizon
VZ
$195B
$2.25M 1.14%
46,032
+2,441
+6% +$118K
BB icon
33
BlackBerry
BB
$5.14B
$1.34M 0.68%
131,130
-2,100
-2% -$16.5K
TWTR
34
DELISTED
Twitter, Inc.
TWTR
$1.27M 0.64%
31,075
+3,475
+13% +$132K
CLDX icon
35
Celldex Therapeutics
CLDX
$3.52B
$1.07M 0.54%
+4,374
New +$988K
NWBO
36
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$760K 0.38%
113,255
+2,480
+2% +$15.8K
OCSL icon
37
Oaktree Specialty Lending
OCSL
$1.12B
$703K 0.36%
23,842
-2,666
-10% -$75.2K
WFC icon
38
Wells Fargo
WFC
$269B
$534K 0.27%
10,163
+3,159
+45% +$159K
BCS.PRA.CL
39
DELISTED
Barclays Bank Plc Series 3
BCS.PRA.CL
$534K 0.27%
20,870
-2,000
-9% -$51.3K
GE icon
40
GE Aerospace
GE
$379B
$476K 0.24%
3,777
-104
-3% -$13.2K
ARRY
41
DELISTED
Array Biopharma Inc
ARRY
$475K 0.24%
104,180
+17,880
+21% +$74K
JNJ icon
42
Johnson & Johnson
JNJ
$629B
$450K 0.23%
4,300
-44,087
-91% -$4.46M
BSX icon
43
Boston Scientific
BSX
$74.5B
$248K 0.13%
19,426
APD icon
44
Air Products & Chemicals
APD
$67.7B
$232K 0.12%
1,946
INTC icon
45
Intel
INTC
$509B
$212K 0.11%
6,868
-2,300
-25% -$63K
VTI icon
46
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
$211K 0.11%
2,073
-100
-5% -$9.86K
GBCI icon
47
Glacier Bancorp
GBCI
$6.4B
-10,000
Closed -$291K
META icon
48
Meta Platforms (Facebook)
META
$1.47T
-46,694
Closed -$2.81M
PII icon
49
Polaris
PII
$3.9B
-1,510
Closed -$211K
MNDT
50
DELISTED
Mandiant, Inc. Common Stock
MNDT
-3,826
Closed -$236K

Similar funds

Bedell Frazier Investment Counselling's Q2 2014 Portfolio in Review

As of Q2 2014, Bedell Frazier Investment Counselling held 55 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Bedell Frazier Investment Counselling's Q2 2014 filing shows 4 new, 21 increased, 19 reduced and 9 closed positions. Its largest new stake was Alphabet (Google) Class C: 382,547 shares worth $11.1M. The largest sale was Johnson & Johnson, an estimated $4.46M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Energy and Communication Services.

  • Bedell Frazier Investment Counselling's largest Q2 2014 buy was Alphabet (Google) Class C: 382,547 shares worth $11.1M.
  • Bedell Frazier Investment Counselling added most to Hasbro in Q2 2014, an estimated $1.83M increase.
  • Bedell Frazier Investment Counselling's biggest Q2 2014 reduction was Johnson & Johnson, cutting an estimated $4.46M.
  • Bedell Frazier Investment Counselling fully exited Weatherford International plc in Q2 2014, selling an estimated $4.21M.
  • Bedell Frazier Investment Counselling's ten largest holdings make up 49% of its $198M portfolio in Q2 2014.
  • Bedell Frazier Investment Counselling opened 4 new positions and closed 9 in Q2 2014.
  • Bedell Frazier Investment Counselling's portfolio value rose 11% quarter-over-quarter to $198M.

Based on Bedell Frazier Investment Counselling's 13F filing for Q2 2014, filed 24 Jul 2014.